Self-StudyCo-Occurring Conditions
Sign In or Register to get started
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 1 Overview
Latent Tuberculosis Infection - 0%Topic 1
BackgroundActivities - 0%Topic 2
Rationale and Indications for LTBI ScreeningActivities - 0%Topic 3
Methods Used to Test for Latent TuberculosisActivities - 0%Topic 4
Recommended LTBI Testing in Persons with HIVActivities - 0%Topic 5
Evaluation of Persons with a Positive LTBI Screening TestActivities - 0%Topic 6
Management of LTBI in Persons with HIVActivities - 0%Topic 7
Considerations in Special PopulationsActivities - 0%Topic 8
Summary PointsActivities - Latent Tuberculosis Infection CE Quiz
Latent Tuberculosis Infection Overview
About this Lesson
Last Updated: February 3rd, 2025
CNE/CME Continuing Education
This lesson qualifies for:
View CE Notices
- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: October 1st, 2017
CNE and CME Review: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to Acquire CE for this Lesson:
1
Quiz
Score 80%+
2
Give Feedback
Complete survey
3
Print CE Certificate
Obtain proof of CE3rd Edition
This is a substantial revision of the original Lesson. The previous edition was titled Latent Tuberculosis Infection and available until September 1st, 2023.
Learning Objectives
- Discuss the epidemiology of tuberculosis and HIV coinfection in the United States
- State the rationale for screening for latent TB in people with HIV
- Describe and compare recommended screening tests for latent TB in people with HIV
- List recommended options for the treatment of latent TB in people with HIV
- Summarize common drug interactions between medications used to treat latent TB and common antiretroviral medications
Lesson Contributors
Authors
Sylvia M. LaCourse, MD, MPH
Sylvia M. LaCourse, MD, MPH
Assistant Professor, Medicine, Global Health, and Epidemiology (Adjunct)
Division of Allergy & Infectious Diseases
University of Washington
Assistant Professor, Medicine, Global Health, and Epidemiology (Adjunct)
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
Grant to Institution: Merck
The relevant financial relationship was mitigated.
Aley G. Kalapila, MD, PhD
Aley G. Kalapila, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Disclosures:
None
Reviewers
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Lesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Question Bank
Interactive board-review style questions about Epidemiology of HIV.
CNE/CME CME+MOC credits and CNE contact hours available.